Source: Annual Congress 2005 - Exploring alternative mechanisms and treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Januskevicius, A. Valiulis, P. Gaidelis, A. Brukstus (Vilnius, Lithuania). New researches on teratogenic and embryogenotoxic effects of iloprost. Eur Respir J 2005; 26: Suppl. 49, 3710

Member's Comments

No comment yet.

Related content which might interest you: New researches on teratogenic and embryogenotoxic effects of tiotropium Source: Eur Respir J 2005; 26: Suppl. 49, 121s Year: 2005 Therapeutic effects of topical calcilytic in IgE/Th2 and alarmin-driven surrogates of human asthma Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019 New insights into the deleterious effects of IH in OSA Source: Research seminar - Targeting the detrimental effects of sleep disturbances and disorders – towards personalized treatment in respiratory diseases Year: 2019 Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma? Source: Eur Respir J 2001; 17: 1059-1061 Year: 2001 Mechanisms of systemic side effects of inhaled steroids Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004 Cardioprotective effects of inhaled corticosteroid-containing combination therapy in COPD Source: Eur Respir J, 53 (2) 1802420; 10.1183/13993003.02420-2018 Year: 2019 Trials of inhaled Iloprost and other new vasodilating prostaglandins Source: Eur Respir J 2001; 17: 6-7 Year: 2001 Comparison of in-vitro anti-fibrotic effects of pirfenidone and nintedanib Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Protective effect of inhaled anticholinergic drugs in the methacholine test Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007 New twists in the pharmacology of NSAID drugs Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment Year: 2007 Persistency of antioxidant/antiinflammatory effects of erdosteine treatment in COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Protective effect of inhaled iloprost on exercise-induced bronchoconstriction Source: Eur Respir J 2004; 24: Suppl. 48, 443s Year: 2004 Ovalbumin-induced asthma model in Brown Norway rats demonstrates potential anti-asthmatic effects of Neu-164, a novel antioxidant and anti-inflammatory compound Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008 Amazing pleiotropic effects of azithromycin Source: Breathe, 14 (4) 336; 10.1183/20734735.025118 Year: 2018 Biomarkers in COPD: Beneficial effects of roflumilast Source: International Congress 2017 – COPD management Year: 2017 Effects of the new ultra-long-acting β2-AR agonist indacaterol in chronic treatment alone or in combination with the β1-AR blocker metoprolol on cardiac remodelling Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Protective effect of inhaled glucocorticosteroids on COPD model. Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Use of anti-inflammatory therapy and asthma mortality in Japan Source: Eur Respir J 2003; 21: 101-104 Year: 2003